Literature DB >> 19289403

Genetic interaction between the m-AAA protease isoenzymes reveals novel roles in cerebellar degeneration.

Paola Martinelli1, Veronica La Mattina, Andrea Bernacchia, Raffaella Magnoni, Federica Cerri, Gregory Cox, Angelo Quattrini, Giorgio Casari, Elena I Rugarli.   

Abstract

The mitochondrial m-AAA protease has a crucial role in axonal development and maintenance. Human mitochondria possess two m-AAA protease isoenzymes: a hetero-oligomeric complex, composed of paraplegin and AFG3L2 (Afg3 like 2), and a homo-oligomeric AFG3L2 complex. Loss of function of paraplegin (encoded by the SPG7 gene) causes hereditary spastic paraplegia, a disease characterized by retrograde degeneration of cortical motor axons. Spg7(-/-) mice show a late-onset degeneration of long spinal and peripheral axons with accumulation of abnormal mitochondria. In contrast, Afg3l2(Emv66/Emv66) mutant mice, lacking the AFG3L2 protein, are affected by a severe neuromuscular phenotype, due to defects in motor axon development. The role of the homo-oligomeric m-AAA protease and the extent of cooperation and redundancy between the two isoenzymes in adult neurons are still unclear. Here we report an early-onset severe neurological phenotype in Spg7(-/-) Afg3l2(Emv66/+) mice, characterized by loss of balance, tremor and ataxia. Spg7(-/-) Afg3l2(Emv66/+) mice display acceleration and worsening of the axonopathy observed in paraplegin-deficient mice. In addition, they show prominent cerebellar degeneration with loss of Purkinje cells and parallel fibers, and reactive astrogliosis. Mitochondria from affected tissues are prone to lose mt-DNA and have unstable respiratory complexes. At late stages, neurons contain structural abnormal mitochondria defective in COX-SDH reaction. Our data demonstrate genetic interaction between the m-AAA isoenzymes and suggest that different neuronal populations have variable thresholds of susceptibility to reduced levels of the m-AAA protease. Moreover, they implicate impaired mitochondrial proteolysis as a novel pathway in cerebellar degeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289403     DOI: 10.1093/hmg/ddp124

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  23 in total

1.  Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation.

Authors:  Ulf Edener; Janine Wöllner; Ute Hehr; Zacharias Kohl; Stefan Schilling; Friedmar Kreuz; Peter Bauer; Veronica Bernard; Gabriele Gillessen-Kaesbach; Christine Zühlke
Journal:  Eur J Hum Genet       Date:  2010-03-31       Impact factor: 4.246

Review 2.  Quality control of mitochondrial proteostasis.

Authors:  Michael J Baker; Takashi Tatsuta; Thomas Langer
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

Review 3.  New roles for mitochondrial proteases in health, ageing and disease.

Authors:  Pedro M Quirós; Thomas Langer; Carlos López-Otín
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05-13       Impact factor: 94.444

4.  Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome.

Authors:  Eleonora Napoli; Catherine Ross-Inta; Sarah Wong; Alicja Omanska-Klusek; Cedrick Barrow; Christine Iwahashi; Dolores Garcia-Arocena; Danielle Sakaguchi; Elizabeth Berry-Kravis; Randi Hagerman; Paul J Hagerman; Cecilia Giulivi
Journal:  Hum Mol Genet       Date:  2011-05-10       Impact factor: 6.150

Review 5.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

6.  Mouse brain expression patterns of Spg7, Afg3l1, and Afg3l2 transcripts, encoding for the mitochondrial m-AAA protease.

Authors:  Tiziana Sacco; Enrica Boda; Eriola Hoxha; Riccardo Pizzo; Claudia Cagnoli; Alfredo Brusco; Filippo Tempia
Journal:  BMC Neurosci       Date:  2010-04-28       Impact factor: 3.288

Review 7.  Mitochondrial Quality Control Proteases in Neuronal Welfare.

Authors:  Roman M Levytskyy; Edward M Germany; Oleh Khalimonchuk
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-02       Impact factor: 4.147

8.  AFG3L2 supports mitochondrial protein synthesis and Purkinje cell survival.

Authors:  Eva R Almajan; Ricarda Richter; Lars Paeger; Paola Martinelli; Esther Barth; Thorsten Decker; Nils-Göran Larsson; Peter Kloppenburg; Thomas Langer; Elena I Rugarli
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

9.  Autocatalytic processing of m-AAA protease subunits in mitochondria.

Authors:  Mirko Koppen; Florian Bonn; Sarah Ehses; Thomas Langer
Journal:  Mol Biol Cell       Date:  2009-08-05       Impact factor: 4.138

10.  Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1.

Authors:  Sarah Ehses; Ines Raschke; Giuseppe Mancuso; Andrea Bernacchia; Stefan Geimer; Daniel Tondera; Jean-Claude Martinou; Benedikt Westermann; Elena I Rugarli; Thomas Langer
Journal:  J Cell Biol       Date:  2009-12-28       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.